Genflow Biosciences plc (LON:GENF)
London · Delayed Price · Currency is GBP · Price in GBX 1.850
+0.050 (2.75%)
Oct 15, 2026, 4:01 PM GMT
Genflow Biosciences Market Cap
Genflow Biosciences has a market cap or net worth of 10.48 million as of October 15, 2026. It is the 39,771st most valuable company in the world and the 878th biggest in the United Kingdom. Its market cap has increased by 11.71% in one year.
Market Cap
10.48M
Enterprise Value
9.84M
Revenue
585.61K
Global Rank
Country Rank
#878 United Kingdom
PE Ratio
n/a
ChartMarket Cap Chart
Since January 17, 2022, Genflow Biosciences's market cap has decreased from 33.64M to 10.48M, a decrease of -68.86%. That is a compound annual growth rate of -21.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 10.48M | 14.73% |
| Dec 31, 2025 | 9.13M | 51.36% |
| Dec 31, 2024 | 6.03M | 44.72% |
| Dec 29, 2023 | 4.17M | -40.63% |
| Dec 30, 2022 | 7.02M | -79.13% |
| Jan 17, 2022 | 33.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| IXICO | 18.61M |
| SkinBioTherapeutics | 16.33M |
| Oxford BioDynamics | 16.13M |
| Aptamer Group | 11.23M |
| Thalia Therapeutics | 11.10M |
| Palatin Technologies | 10.32M |
| Solvonis Therapeutics | 7.49M |
| CRISM Therapeutics | 6.73M |